| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 51.89B | 89.23B | 119.46B | 116.54B | 169.54B |
| Gross Profit | 12.01B | 14.98B | 16.17B | 17.37B | 29.93B |
| EBITDA | 7.03B | 7.03B | 7.83B | 5.64B | 17.88B |
| Net Income | 383.21M | 491.31M | 879.30M | 280.67M | 8.59B |
Balance Sheet | |||||
| Total Assets | 266.72B | 309.12B | 377.09B | 463.47B | 540.11B |
| Cash, Cash Equivalents and Short-Term Investments | 7.05B | 7.47B | 13.81B | 24.13B | 48.84B |
| Total Debt | 57.20B | 59.06B | 64.55B | 80.22B | 104.93B |
| Total Liabilities | 185.13B | 222.34B | 286.58B | 370.46B | 442.69B |
| Stockholders Equity | 46.60B | 46.35B | 45.87B | 44.75B | 42.16B |
Cash Flow | |||||
| Free Cash Flow | -1.97B | -2.69B | 5.72B | 6.31B | 14.13B |
| Operating Cash Flow | -1.93B | -2.64B | 6.00B | 7.46B | 15.60B |
| Investing Cash Flow | 1.41B | 2.51B | 3.66B | -218.47M | -21.72B |
| Financing Cash Flow | -1.71B | -6.13B | -18.88B | -31.47B | -6.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | HK$10.01B | -1.82 | -2.88% | ― | -11.68% | -3002.05% | |
46 Neutral | HK$18.65B | 12.03 | 1.53% | 2.46% | -8.18% | ― | |
41 Neutral | HK$15.20B | 33.84 | 0.46% | ― | -30.32% | ― | |
40 Underperform | HK$5.34B | -24.06 | -25.72% | ― | -54.25% | -134.22% | |
39 Underperform | HK$13.39B | 3.16 | -3.01% | ― | -19.37% | 72.77% |